Catalyst Wire Dossier Catalyst Wire Dossier
EMA safety_alert · 2012-02-16

European Medicines Agency informs doctors and patients about drug interaction between Victrelis and ritonavir-boosted HIV protease inhibitors

View source ↗

Summary

EMA informs about drug interaction between Victrelis (boceprevir) and ritonavir-boosted HIV protease inhibitors, advising clinicians and patients on potential i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Victrelis (boceprevir)
  • ritonavir-boosted HIV protease inhibitors